Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Fusion Pharmaceuticals secures rights for advanced prostate cancer treatment from Heidelberg University and Euratom Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a trailblazer in the oncology sector specializing in the development of next-generation radiopharmaceuticals,… byPallavi MadhirajuFebruary 18, 2024